Login to Your Account

Federal Circuit gives patents new wiggle room in Cellzdirect

By Mark McCarty
Regulatory Editor

Saturday, July 9, 2016

Life sciences patents have not fared well in recent case law, including several cases ruled on by the U.S. Supreme Court, but the Court of Appeals for the Federal Circuit has returned a verdict in the case of Rapid Litigation Management v. Cellzdirect, a case that is seen by some as favorable toward patents that invoke natural law and favorable to commercial activity in life sciences.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription